Evidence map›Paper›PMID 32587405›Full record

ArticleNature reviews. Urology2020

Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research.

Muhammad Imran Omar, Monique J Roobol, Maria J Ribal, Thomas Abbott, Paul-Michael Agapow, Sonia Araujo, Alex Asiimwe, Charles Auffray, Irina Balaur, Katharina Beyer and 37 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature reviews. Urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

47 authors.

Muhammad Imran OmarAcademic Urology Unit, University of Aberdeen, Aberdeen, UK. m.i.omar@abdn.ac.uk.ORCID http://orcid.org/0000-0002-1597-3126
Monique J RoobolErasmus MC, Rotterdam, Netherlands.ORCID http://orcid.org/0000-0001-6967-1708
Maria J RibalGuidelines Office, European Association of Urology, Arnhem, Netherlands.
Thomas AbbottAstellas, Leiden, The Netherlands.
Paul-Michael AgapowImperial College London, London, UK.ORCID http://orcid.org/0000-0003-1126-1479
Sonia AraujoIQVIA, London, UK.
Alex AsiimweBayer AG, Berlin, Germany.ORCID http://orcid.org/0000-0002-7633-0220
Charles AuffrayAssociation EISBM, Vourles, France.ORCID http://orcid.org/0000-0003-2226-7411
Irina BalaurAssociation EISBM, Vourles, France.ORCID http://orcid.org/0000-0002-3671-895X
Katharina BeyerTranslational Oncology and Urology Research, King's College London, London, UK.
Chiara BerniniEuropean Alliance for Personalised Medicine (EAPM), Brussels, Belgium.
Anders BjartellDepartment of Translational Medicine, Lund University, Lund, Sweden.
Alberto BrigantiDepartment of Urology and Division of Experimental Oncology, Urological Research Institute, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
John-Edward Butler-RansohoffBayer AG, Berlin, Germany.
Riccardo CampiGuidelines Office, European Association of Urology, Arnhem, Netherlands.ORCID http://orcid.org/0000-0001-5237-0888
Marinel CavelaarsThe Hyve, Utrecht, Netherlands.
Bertrand De MeulderAssociation EISBM, Vourles, France.
Zsuzsanna DevecseriSanofi, Chilly-Mazarin, France.ORCID http://orcid.org/0000-0001-7648-3633
Marc Dietrich VossSanofi, Chilly-Mazarin, France.ORCID http://orcid.org/0000-0001-8618-766X
Konstantinos DimitropoulosGuidelines Office, European Association of Urology, Arnhem, Netherlands.
Susan Evans-AxelssonDepartment of Translational Medicine, Lund University, Lund, Sweden.ORCID http://orcid.org/0000-0002-4240-0550
Billy FranksAstellas, Leiden, The Netherlands.
Louise FullwoodPinsent Masons, Leeds, UK.
Denis HorganEuropean Alliance for Personalised Medicine (EAPM), Brussels, Belgium.
Emma Jane SmithGuidelines Office, European Association of Urology, Arnhem, Netherlands.
Amit KiranAstellas, Leiden, The Netherlands.
Kati KivinummiTampere University (TAU), Tampere, Finland.ORCID http://orcid.org/0000-0002-5788-835X
Mark LambrechtSAS, Tervuren, Belgium.
Doron LancetWeizmann Institute, Rehovot, Israel.
Peter LindgrenThe Swedish Institute for Health Economics (IHE), Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8238-8189
Sara MacLennanAcademic Urology Unit, University of Aberdeen, Aberdeen, UK.ORCID http://orcid.org/0000-0003-1405-6964
Steven MacLennanAcademic Urology Unit, University of Aberdeen, Aberdeen, UK.ORCID http://orcid.org/0000-0002-2691-8421
Maria Manuela NogueiraAssociation EISBM, Vourles, France.ORCID http://orcid.org/0000-0002-8353-1979
Fredrik MoenThe Swedish Institute for Health Economics (IHE), Stockholm, Sweden.ORCID http://orcid.org/0000-0003-2428-4485
Maxim MoinatThe Hyve, Utrecht, Netherlands.
Kishore PapineniAstellas, Leiden, The Netherlands.
Christian ReichIQVIA, London, UK.
Kristin ReicheFraunhofer IZI, Leipzig, Germany.ORCID http://orcid.org/0000-0002-4452-4872
Stijn RogiersSAS, Tervuren, Belgium.
Claudio SartiniBayer AG, Berlin, Germany.
Kees van BochoveThe Hyve, Utrecht, Netherlands.ORCID http://orcid.org/0000-0002-8589-0609
Femke van Diggelenttopstart, Utrecht, Netherlands.ORCID http://orcid.org/0000-0001-6211-0529
Mieke Van HemelrijckTranslational Oncology and Urology Research, King's College London, London, UK.
Hein Van PoppelGuidelines Office, European Association of Urology, Arnhem, Netherlands.ORCID http://orcid.org/0000-0002-7458-8578
Jihong ZongBayer AG, Berlin, Germany.
James N'DowGuidelines Office, European Association of Urology, Arnhem, Netherlands.
PIONEER Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32587405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.